1. Home
  2. MRSN vs BEEM Comparison

MRSN vs BEEM Comparison

Compare MRSN & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • BEEM
  • Stock Information
  • Founded
  • MRSN 2001
  • BEEM 2006
  • Country
  • MRSN United States
  • BEEM United States
  • Employees
  • MRSN N/A
  • BEEM N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • BEEM Semiconductors
  • Sector
  • MRSN Health Care
  • BEEM Technology
  • Exchange
  • MRSN Nasdaq
  • BEEM Nasdaq
  • Market Cap
  • MRSN 37.0M
  • BEEM 35.5M
  • IPO Year
  • MRSN 2017
  • BEEM N/A
  • Fundamental
  • Price
  • MRSN $7.66
  • BEEM $2.58
  • Analyst Decision
  • MRSN Strong Buy
  • BEEM Strong Buy
  • Analyst Count
  • MRSN 3
  • BEEM 4
  • Target Price
  • MRSN $33.00
  • BEEM $5.33
  • AVG Volume (30 Days)
  • MRSN 90.2K
  • BEEM 189.9K
  • Earning Date
  • MRSN 08-13-2025
  • BEEM 08-14-2025
  • Dividend Yield
  • MRSN N/A
  • BEEM N/A
  • EPS Growth
  • MRSN N/A
  • BEEM N/A
  • EPS
  • MRSN N/A
  • BEEM N/A
  • Revenue
  • MRSN $34,769,000.00
  • BEEM $33,362,000.00
  • Revenue This Year
  • MRSN N/A
  • BEEM N/A
  • Revenue Next Year
  • MRSN N/A
  • BEEM $44.48
  • P/E Ratio
  • MRSN N/A
  • BEEM N/A
  • Revenue Growth
  • MRSN 16.14
  • BEEM N/A
  • 52 Week Low
  • MRSN $5.21
  • BEEM $1.33
  • 52 Week High
  • MRSN $70.75
  • BEEM $5.57
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 54.20
  • BEEM 52.52
  • Support Level
  • MRSN $6.63
  • BEEM $2.41
  • Resistance Level
  • MRSN $7.25
  • BEEM $3.07
  • Average True Range (ATR)
  • MRSN 0.52
  • BEEM 0.18
  • MACD
  • MRSN 0.02
  • BEEM -0.03
  • Stochastic Oscillator
  • MRSN 65.86
  • BEEM 34.78

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

Share on Social Networks: